![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 1, 27-30, Jan, 1984
JM Wilson and WN Kelley
HPRTMunich is a mutant form of human hypoxanthine-guanine
phosphoribosyltransferase that was isolated from a patient who presented
with gout and a partial deficiency of enzyme activity. Profound
abnormalities in the catalytic function of HPRTMunich are responsible for
the deficiency of enzyme activity in vivo. Tryptic peptides of HPRTMunich
were mapped by reverse phase high pressure liquid chromatography in an
attempt to define the precise abnormality in its primary structure.
Sequence analysis of aberrant peptides localized the structural alteration
in HPRTMunich to residue 103. Several additional findings suggest that the
mutation in this variant is most likely a serine to arginine substitution
at residue 103. This amino acid substitution lies within the putative
hypoxanthine-binding site of human hypoxanthine-guanine
phosphoribosyltransferase possibly explaining its selective effect on
intrinsic enzyme activity and binding of hypoxanthine.
Human hypoxanthine-guanine phosphoribosyltransferase. Structural alteration in a dysfunctional enzyme variant (HPRTMunich) isolated from a patient with gout
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. S. Kim and W. G. Thilly Ligation of high-melting-temperature 'clamp' sequence extends the scanning range of rare point-mutational analysis by constant denaturant capillary electrophoresis (CDCE) to most of the human genome Nucleic Acids Res., August 15, 2003; 31(16): e97 - e97. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Craig III and A. E. Eakin Purine Phosphoribosyltransferases J. Biol. Chem., June 30, 2000; 275(27): 20231 - 20234. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |